Cannabix Technologies, Inc. (BLOZF)

BLO_logoAs marijuana rises in popularity and legitimacy, companies are flocking to answer the various needs that come with it. From research, cultivation, processing, and marketing, all the way up to commercial and personal use, the many aspects of the industry are covered by new and existing businesses. However, the Vancouver, Canada-based Cannabix Technologies, Inc stands out because it caters to the field of law enforcement through its Marijuana Breathalyzer.

Cannabix Technologies, Inc is a technology company whose prime product is the Cannabix Marijuana Breathalyzer, a drug-impairment recognition device. Much like the common alcohol breathalyzer, it is a tool that can be used by law enforcers to determine a person’s drug intoxication through breath testing. The Marijuana Breathalyzer analyzes breath samples and detects tetrahydrocannabinol (THC), which is the psychoactive component of marijuana and has been found to cause intoxication.

The breath-testing technology in the Cannabix Marijuana Breathalyzer emerged from a study in Sweden. Kal Malhi, a former Canada Mountie (member of the Royal Canadian Mounted Police) and current Cannabix President, saw the importance of this technology to identify drivers who are high. The company touts its product as a tool to inhibit marijuana-intoxicated drivers as well as employees whose THC intoxication could be hazardous in the workplace.

Cannabix Technologies started out in 2011 as West Point Resources, Inc, an earlier developer of the cannabis breathalyzer under the brand name Cannabix. The company then changed its name to Cannabix Technologies, Inc only in August 2014.

Currently, Cannabix Technologies is traded in the Canadian Securities Exchange as BLO and in the US OTC markets as BLOZF. It has a market cap of USD 7.4 M. Its top officers are Rav Mlait, CEO; Kal Malhi, President; Dr. Raj Attariwala, Chief Engineer; Dr. Bruce Goldberger, Senior Advisor; and Bryan Loree, CFO.


Yahoo! Finance: BLOZF News

Latest Financial News for BLOZF

Cannabix Technologies Achieves THC Breath Capture Milestone, Comments on Patent Portfolio

Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that Company scientists have developed proprietary methods resulting in the achievement of the highest ∆9-tetrahydrocannabinol (“THC”) detection levels collected from human breath to date. Over the last several months, Company scientists have studied the unique chemical interactions of THC and cannabinoids in breath, and developed and evaluated novel methods to efficiently and practically capture and ionize THC and cannabinoid analytes collected from several different subjects.

Cannabix Technologies Makes Advances with Marijuana Breathalyzer Development and THC Breath Capture

The Cannabix Marijuana Breathalyzer is being developed to provide law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, July 15, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company” or “Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that Company scientists have made significant advancements with analyte in breath capture and FAIMS cell development.  Cannabix scientists have been optimizing the breath / sample capture procedures and technology to maximize ∆9-tetrahydrocannabinol (“THC”) analyte capture from human breath.

Cannabix Technologies Makes Advances with Marijuana Breathalyzer Development and Renews Research with Yost Group

The Cannabix Marijuana Breathalyzer system is being developed to give law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, May 29, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that Company engineers have made a significant breakthrough with the ionization module which is a vital component of the breathalyzer device, where breath samples are ionized prior to entrance into the FAIMS cell. The Company also reports that it has been steadily progressing with human breath testing at its Vancouver, BC, based lab with its FAIMS (field asymmetric waveform ion mobility spectrometry) ∆9-tetrahydrocannabinol (“THC”) detection device and breath collection unit (“BCU”).

Cannabix Technologies Adds Dr. Randall Purves as Scientific Advisor

The Cannabix Marijuana Breathalyzer system is being developed to give law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, May 13, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company”) is pleased to announce that Dr. Randy Purves has been appointed as a Scientific Advisor to Cannabix Technologies Inc. Dr. Purves is one of the world’s foremost experts in the development of FAIMS (high-field asymmetric waveform ion mobility spectrometry) instrumentation and applications. Dr. Purves is a pioneer in developing FAIMS technology and in 2001 he co-founded Ionalytics, an instrument company specializing in FAIMS devices for use with mass spectrometry.

Approved Roadside Saliva Test Faces Court Challenge in Canada -- CFN Media

Seattle, Washington--(Newsfile Corp. - April 30, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article discussing Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) and its development of the Cannabix Marijuana Breathalyzer, seeking to provide consistent, convenient, and accurate THC detection for both law enforcement and workplace applications.In August of 2018 the Canadian federal government approved ...